Biobank
/
Eastern Norway

Bionor Immuno AS
Biomedical drug development company

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 40
    Operating profit:-11.348
    Operating profit before tax: -12.097
    Total assets: 901
    Total equity:-824
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Birger Sørensen

    Board Members:
    Birger Sørensen
    Dag Arne Wivelstad

    General Manager:
    Birger Sørensen

    Subsidiary companies:
    Largest shareholders:
    N/A
    Biobank, Biomedical equipment, Biotechnology, Health Care, Medical analysis services, Pharmacological Treatments (New Medicines & Therapies), Terapeutica, Therapeutic agents, Vaccines,